SCHEMBL30289100

SCHEMBL30289100

Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(CCC(=O)N3CCN(C(=O)OC(C)(C)C)[C@H](C(=O)OC(C)(C)C)C3)cc21

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 20/20 0.50
▸ DDB1 Q16531 18/20 0.50
▸ GSPT1 P15170 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30289150 0.94 DDB1 (0.47) CRBNDDB1
SCHEMBL30289538 0.94 DDB1 (0.47) CRBNDDB1
SCHEMBL30289499 0.90 CRBN (0.51) CRBNDDB1GSPT1
SCHEMBL26098625 0.89 DDB1 (0.56) CRBNDDB1
SCHEMBL30289299 0.87 CRBN (0.52) CRBNDDB1
SCHEMBL30289000 0.86 CRBN (0.48) CRBNDDB1GSPT1
SCHEMBL30289502 0.84 CRBN (0.51) CRBNDDB1GSPT1
SCHEMBL30289153 0.84 CRBN (0.51) CRBNDDB1GSPT1
SCHEMBL26100659 0.84 CRBN (0.51) CRBNDDB1
SCHEMBL31218849 0.83 CRBN (0.51) CRBNDDB1GSPT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405359-A2 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-31 — — EP disclosed
WO-2023049790-A2 MDM2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-30 — — WO disclosed
Send feedback